IGC Stock Analysis: Buy, Sell, or Hold?
IGC - IGC Pharma, Inc.
$0.31
0.00 (-0.77%)
▼
5d:
-11.37%
30d:
+21.76%
90d:
+8.4%
HOLD
MODERATE Confidence
Analysis Updated: Apr 29, 2026 12:00 AM ET
Earnings: Jun 15, 2026
Get Alerted When IGC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: IGC shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: IGC shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: IGC is currently trading at $0.31, which is considered extended relative to its 30-day fair value range of $0.26 to $0.32.
Technical Outlook: Technically, IGC is in a uptrend. Immediate support is located at $0.29, while resistance sits at $0.36.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $4.12 (+1215.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, IGC is in a uptrend. Immediate support is located at $0.29, while resistance sits at $0.36.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $4.12 (+1215.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$0.26 -
$0.32
Company Quality Score
49/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
45.8%
All Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: Trading 1215.8% below Wall St target ($4.12)
- CAUTION: 5-day price weakness (-11.4%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$0.26 -
$0.32
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$0.29
Resistance Level
$0.36
Current Trend
Uptrend
Technical data as of
Apr 29, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.48
Wall Street Target
$4.13
(+1215.8%)
Revenue Growth (YoY)
-53.6%
Share & Embed Analysis
Last updated: April 29, 2026 2:41 PM ET
Data refreshes hourly during market hours. Next update: 3:41 PM
Data refreshes hourly during market hours. Next update: 3:41 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IGC showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$25 | 48 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$408 | 47 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$224 | 54 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$107 | 64 BUY |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$84 | 57 HOLD |
